Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-068103
Filing Date
2025-07-15
Accepted
2025-07-15 16:19:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2518735-1_424b5.htm 424B5 597314
2 GRAPHIC fc_productpipe-4c.jpg GRAPHIC 68600
3 GRAPHIC lg_gaintherapeutics-4c.jpg GRAPHIC 14481
4 GRAPHIC tb_ourpipelinestars-4c.jpg GRAPHIC 61359
  Complete submission text file 0001104659-25-068103.txt   795983
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-265061 | Film No.: 251125004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)